ABVC BioPharma, Inc. Fair Value of Assets Acquired
ABVC BioPharma, Inc. (ABVC) reported Fair Value of Assets Acquired of $7.67 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueOfAssetsAcquired · last filed 2025-08-13
- ABVC BioPharma, Inc. fair value of assets acquired for the quarter ending 2025-06-30 was $0.00.
- ABVC BioPharma, Inc. fair value of assets acquired for the quarter ending 2025-03-31 was $7.67M, a 3.65% increase year-over-year.
- ABVC BioPharma, Inc. fair value of assets acquired for the quarter ending 2024-06-30 was $0.00.
- ABVC BioPharma, Inc. fair value of assets acquired for the quarter ending 2024-03-31 was $7.40M.
- ABVC BioPharma, Inc. fair value of assets acquired for fiscal 2023 was $7.40M.
| Period end | Fair Value of Assets Acquired 3 month | Fair Value of Assets Acquired 6 month | Fair Value of Assets Acquired 9 month | Fair Value of Assets Acquired 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $7.67M 10-Q · filed 2025-08-13 | ||
| 2025-03-31 | $7.67M 10-Q · filed 2025-04-30 | |||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $7.40M 10-Q · filed 2024-08-14 | $7.40M derived: sum of 3 quarters · filed 2024-08-14 | |
| 2024-03-31 | $7.40M 10-Q · filed 2024-05-17 | $7.40M derived: sum of 2 quarters · filed 2024-05-17 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $7.40M 10-K · filed 2024-03-13 | ||
| 2023-09-30 | $7.40M 10-Q · filed 2023-11-15 |